Priya Rastogi: monarchE, PENELOPE-B and RxPonder from a presenter's point of view
Abstracts GS1-01, GS1-02, GS3-00
Wolfgang Janni, Diana Lüftner, Christian Jackisch
Wolfgang Janni: CTC are effective as early treatment monitoring tool
Abstract GS4-07, GS4-00
Nadia Harbeck, Peter Fasching, Diana Lüftner
Nadia Harbeck: ADAPT - We can spare young patients from Chemotherapy...
zum Abstract GS4-04
Sare Tolaney, Michael P. Lux, Diana Lüftner
Sara Tolaney: Deescalation approaches: RxPONDER – are we ready for deescalation: premenopausal vs. postmenopausal patients, who needs chemotherapy? APT & TRAIN-2: Can we omit Anthracyclines in smaller tumors?